Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Halley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Discovery Today. Therapeutic Strategies|January 13, 2015
Natural antisense transcripts as therapeutic targetsPaul Halley, Olga Khorkova, Claes Wahlestedt
Neuroscience Letters|November 5, 2020
Behavioural phenotyping of thunder mice with a hypomorphic mutation of heterogeneous nuclear ribonuclear protein L-like (hnRNPLL) and reduced T cell functionMaarten van den Buuse, Paul Halley, Gerard F Hoyne
Journal of Neural Transmission (Vienna, Austria : 1996)|May 18, 2012
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanismsManfred Gerlach, Paul Halley, Peter Riederer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 25, 2012
Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activityMaarten van den Buuse, Paul Halley, Rachel Hill, et al.
Cell Reports|January 7, 2014
Regulation of the apolipoprotein gene cluster by a long noncoding RNAPaul Halley, Beena M Kadakkuzha, Mohammad Ali Faghihi, et al.
Frontiers in Cellular Neuroscience|August 28, 2014
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticityGraham K Sheridan, Anita Wdowicz, Mark Pickering, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memoryClaude-Henry Volmar, Hasib Salah-Uddin, Karolina J Janczura, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Discovery Today. Therapeutic Strategies|January 13, 2015
Natural antisense transcripts as therapeutic targetsPaul Halley, Olga Khorkova, Claes Wahlestedt
Neuroscience Letters|November 5, 2020
Behavioural phenotyping of thunder mice with a hypomorphic mutation of heterogeneous nuclear ribonuclear protein L-like (hnRNPLL) and reduced T cell functionMaarten van den Buuse, Paul Halley, Gerard F Hoyne
Journal of Neural Transmission (Vienna, Austria : 1996)|May 18, 2012
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanismsManfred Gerlach, Paul Halley, Peter Riederer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 25, 2012
Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activityMaarten van den Buuse, Paul Halley, Rachel Hill, et al.
Cell Reports|January 7, 2014
Regulation of the apolipoprotein gene cluster by a long noncoding RNAPaul Halley, Beena M Kadakkuzha, Mohammad Ali Faghihi, et al.
Frontiers in Cellular Neuroscience|August 28, 2014
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticityGraham K Sheridan, Anita Wdowicz, Mark Pickering, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memoryClaude-Henry Volmar, Hasib Salah-Uddin, Karolina J Janczura, et al.
Pageof 1